Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Elizabeth Davis, Ana G. Antun, MD, Lisa Baumann Kreuziger, MD MS, J. Evan Sadler, MD PhD, Spero R Cataland, MD, Meera Sridharan, MD, Todd Clover, MD, Andrew Johnson, MD, Keith McCrae, MD, Shruti Chaturvedi, MBBS,MS, Ronald S. Go, MD, Ming Yeong Lim, MBBChir, Marshall A. Mazepa, MD

Blood (2017) 130 (Supplement 1): 1049.

https://doi.org/10.1182/blood.V130.Suppl_1.1049.1049

Published: 2017

Journal Articles

Risk Factors Associated with Multiple End-Organ Damage in Idiopathic Thrombotic Thrombocytopenic Purpura (TTP) Patients

Limin Gao, MD MPH and PhD, Grace Kao, MD

Blood (2016) 128 (22): 4928.

https://doi.org/10.1182/blood.V128.22.4928.4928

Published: 2016

Journal Articles

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Yumi Yoshii, MD, Masanori Matsumoto, MD PhD, Kurumatani Norio, MD PhD, Ayami Isonishi, BS, Masahito Uemura, MD PhD, Yuji Hori, PhD, Masaki Hayakawa, MD, Hideo Yagi, MD PhD, Charles L Bennett, MD PhD MPP, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 4209.

https://doi.org/10.1182/blood.V124.21.4209.4209

Published: 2014

Journal Articles

Derivation and Prospective Validation of a Predictive Score for the Rapid Diagnosis of Thrombotic Thrombocytopenic Purpura: The Plasmic Score

Pavan K Bendapudi, MD, Ang Li, MD, Ayad Hamdan, MD, Ashley Michelle Fry, MD, Lynne Uhl, MD, Marisa Marques, MD, Richard Kaufman, MD, Christopher P. Stowell, MD PhD, Walter Sunny Dzik, MD, Robert S Makar, MD PhD

Blood (2014) 124 (21): 231.

https://doi.org/10.1182/blood.V124.21.231.231

Published: 2014

Journal Articles

Detectable Or Normal ADAMTS13 Activity In Patients Presenting With Thrombotic Thrombocytopenic Purpura (TTP) Is Associated With Poor Renal Outcomes

Shruti Chaturvedi, MD, Keith R. McCrae, MD, Desiree Carcioppolo, MS

Blood (2013) 122 (21): 4752.

https://doi.org/10.1182/blood.V122.21.4752.4752

Published: 2013

Journal Articles

Impact Of Patient, Disease and Plasma Exchange Characteristics On The Outcomes Of Thrombotic Thrombocytopenic Purpura In a Retrospective Cohort Study

Amna G Khattak, Mansoor Ul Haq, MD, Fnu Kaweeta, MD, Mehmet Kocak, Ph D, Robert Bradley, Alva B. Weir, MD

Blood (2013) 122 (21): 2359.

https://doi.org/10.1182/blood.V122.21.2359.2359

Published: 2013

Journal Articles

Utilization Of ADAMTS13 Testing In Suspected Thrombotic Thrombocytopenic Purpura (TTP)

Mijung Lee, MD, Colin A Hardin, MD, Bonnie Chapman, MPH, Steven M. Duffy, MD, Zhanna Spektor, MD, Ajeet Gajra, MD, MBBS

Blood (2013) 122 (21): 2953.

https://doi.org/10.1182/blood.V122.21.2953.2953

Published: 2013

Journal Articles

Prospective Evaluation of a TTP Prediction Score in an Independent Cohort

Melissa J. Bentley, M.D., Andrew Wilson, George M Rodgers, MD, PhD

Blood (2012) 120 (21): 1093.

https://doi.org/10.1182/blood.V120.21.1093.1093

Published: 2012

Journal Articles

Importance of Measuring Circulating ADAMTS13 Immune Complexes in Addition to Free Antibodies in Patients with Acquired TTP

Silvia Ferrari, PhD, Barbara Plaimauer, PhD, Bernadette Gruber, Kristina Palavra, Peter L Turecek, PhD, Hartmut J. Ehrlich, MD, Hanspeter Rottensteiner, PhD, Friedrich Scheiflinger, PhD

Blood (2012) 120 (21): 102.

https://doi.org/10.1182/blood.V120.21.102.102

Published: 2012

Journal Articles

ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates

Flora Peyvandi, Pier Mannuccio Mannucci, MD, Carla Valsecchi, Silvia Pontiggia, Jonathan Bernstein, MS, MD, Stefano Guazzini, PhD, Anastassios Retzios, PhD

Blood (2012) 120 (21): 3383.

https://doi.org/10.1182/blood.V120.21.3383.3383

Published: 2012

Journal Articles

Retrospective Analysis of Patients Afflicted with Thrombotic Thrombocytopenic Purpura: A Single Institutional Experience.

Manali K. Kamdar, MD, Phillip Chae, Maria Javaid, Negin Mesaghian, Kevin O'Brien, Tejas Desai, Darla K Liles, MD

Blood (2012) 120 (21): 2200.

https://doi.org/10.1182/blood.V120.21.2200.2200

Published: 2012

Journal Articles

Antibody Against Macrophage Receptor with Collagenous Structure (Anti-MARCO IgG) in Thrombotic Thrombocytopenic Purpura Patients.

Phandee Watanaboonyongcharoen, MD, Jessica L. Allen, PhD, Yuri D. Fedoriw, MD, Herbert C. Whinna, MD, PhD, Rommel P. Lu, MD, Yara A. Park, MD, Stefanie Sarantopoulos, MD, PhD

Blood (2012) 120 (21): 2201.

https://doi.org/10.1182/blood.V120.21.2201.2201

Published: 2012

Journal Articles

von Willebrand Factor-ADAMTS13 Interactions

X. Long Zheng, MD, PhD

Blood (2012) 120 (21): SCI-18.

https://doi.org/10.1182/blood.V120.21.SCI-18.SCI-18

Published: 2012

Journal Articles

Ectopic Expression of ADAMTS13 in Platelets As a Novel Therapeutic Approach for Arterial Thrombosis

Brandy Pickens, PhD, Sheng-Yu Jin, MD, PhD, Dengju Li, MD, PhD, X. Long Zheng, MD, PhD

Blood (2012) 120 (21): 491.

https://doi.org/10.1182/blood.V120.21.491.491

Published: 2012

Journal Articles

Efficacy of 5% Albumin and Fresh Frozen Plasma (AFFP) Versus Fresh Frozen Plasma (FFP) only as Replacement fluid in Plasma Exchange for Thrombotic Thrombocytopenic Purpura (TTP)

James Louie, MD, Fouad Boctor, MD, Jason Chiang, MD, Zeeshan Anwar, Amanda Wittenberg, Elena Gogas

Blood (2012) 120 (21): 272.

https://doi.org/10.1182/blood.V120.21.272.272

Published: 2012

Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

Ayami Isonishi, BS, Masanori Matsumoto, MD, PhD, Friedrich Scheiflinger, PhD, Barbara Plaimauer, PhD, Charles Bennett, MD, PhD, MPP, Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 1086.

https://doi.org/10.1182/blood.V120.21.1086.1086

Published: 2012

Journal Articles

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Cui Jian, Juan Xiao, Lingjie Gong, Christopher G. Skipwith, Sheng-Yu Jin, Hau C. Kwaan, X. Long Zheng

Blood (2012) 119 (16): 3836–3843.

https://doi.org/10.1182/blood-2011-12-399501

Published: 2012

Includes: Multimedia, Supplemental data

Journal Articles

ADAMTS13 Helps Distinguish Thrombotic Thrombocytopenic Purpura From Other Microangiopathies and Guide Necessity of Plasma Exchange Therapy

Neil Shah, M.D., Karen Matevosyan, MD, James Burner, M.D., Ravindra Sarode, MD

Blood (2011) 118 (21): 2328.

https://doi.org/10.1182/blood.V118.21.2328.2328

Published: 2011

Journal Articles

An Optimized Fluorogenic Assay with Increased Sensitivity for ADAMTS13 Activity and Inhibitors for the Characterization of Patients with Thrombotic Thrombocytopenic Purpura,

Joshua Muia, Ph.D., Weiqiang Gao, MD, PhD, J. Evan Sadler, MD, PhD

Blood (2011) 118 (21): 3298.

https://doi.org/10.1182/blood.V118.21.3298.3298

Published: 2011

Journal Articles

The Prognostic Effects of Anti-ADAMTS13 IgG, IgA and IgM Antibody Subclasses In Acute Idiopathic TTP and the Effect of Rituximab,

Vickie McDonald, MA, MRCP, FRCPath, Samuel J Machin, MD FRCPath, Ian J Mackie, PhD FRCPath, Marie A Scully, MD FRCPath

Blood (2011) 118 (21): 3305.

https://doi.org/10.1182/blood.V118.21.3305.3305

Published: 2011

NARROW

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Risk Factors Associated with Multiple End-Organ Damage in Idiopathic Thrombotic Thrombocytopenic Purpura (TTP) Patients

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Derivation and Prospective Validation of a Predictive Score for the Rapid Diagnosis of Thrombotic Thrombocytopenic Purpura: The Plasmic Score

Detectable Or Normal ADAMTS13 Activity In Patients Presenting With Thrombotic Thrombocytopenic Purpura (TTP) Is Associated With Poor Renal Outcomes

Impact Of Patient, Disease and Plasma Exchange Characteristics On The Outcomes Of Thrombotic Thrombocytopenic Purpura In a Retrospective Cohort Study

Utilization Of ADAMTS13 Testing In Suspected Thrombotic Thrombocytopenic Purpura (TTP)

Prospective Evaluation of a TTP Prediction Score in an Independent Cohort

Importance of Measuring Circulating ADAMTS13 Immune Complexes in Addition to Free Antibodies in Patients with Acquired TTP

ADAMTS13 Content of Plasma-Derived Factor VIII-Von Willebrand Factor Concentrates

Retrospective Analysis of Patients Afflicted with Thrombotic Thrombocytopenic Purpura: A Single Institutional Experience.

Antibody Against Macrophage Receptor with Collagenous Structure (Anti-MARCO IgG) in Thrombotic Thrombocytopenic Purpura Patients.

von Willebrand Factor-ADAMTS13 Interactions

Ectopic Expression of ADAMTS13 in Platelets As a Novel Therapeutic Approach for Arterial Thrombosis

Efficacy of 5% Albumin and Fresh Frozen Plasma (AFFP) Versus Fresh Frozen Plasma (FFP) only as Replacement fluid in Plasma Exchange for Thrombotic Thrombocytopenic Purpura (TTP)

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

ADAMTS13 Helps Distinguish Thrombotic Thrombocytopenic Purpura From Other Microangiopathies and Guide Necessity of Plasma Exchange Therapy

An Optimized Fluorogenic Assay with Increased Sensitivity for ADAMTS13 Activity and Inhibitors for the Characterization of Patients with Thrombotic Thrombocytopenic Purpura,

The Prognostic Effects of Anti-ADAMTS13 IgG, IgA and IgM Antibody Subclasses In Acute Idiopathic TTP and the Effect of Rituximab,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only